STOCK TITAN

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Negative)
Tags
conferences
NanoVibronix, Inc. (Nasdaq: NAOV) will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024. The CEO, Brian Murphy, will host the presentation. Investors can access the live webcast and book 1x1 meetings at the conference venue.
NanoVibronix, Inc. (Nasdaq: NAOV) sarà presente al Planet MicroCap Showcase: VEGAS 2024 il 1° maggio 2024. La presentazione sarà tenuta dal CEO Brian Murphy. Gli investitori potranno accedere alla trasmissione web dal vivo e prenotare incontri individuali presso la sede della conferenza.
NanoVibronix, Inc. (Nasdaq: NAOV) se presentará en el Planet MicroCap Showcase: VEGAS 2024 el 1 de mayo de 2024. El CEO, Brian Murphy, estará a cargo de la presentación. Los inversores podrán acceder a la transmisión en vivo y reservar reuniones uno a uno en el lugar de la conferencia.
나노바이브로닉스, 인크(Nasdaq: NAOV)는 2024년 5월 1일에 개최되는 플래닛 마이크로캡 쇼케이스: 베이거스 2024에 참가할 예정입니다. CEO 브라이언 머피가 발표를 진행할 것입니다. 투자자들은 컨퍼런스 현장에서 라이브 웹캐스트를 접속하고 1대1 미팅을 예약할 수 있습니다.
NanoVibronix, Inc. (Nasdaq: NAOV) présentera au Planet MicroCap Showcase : VEGAS 2024 le 1er mai 2024. Le PDG, Brian Murphy, animera la présentation. Les investisseurs pourront accéder à la webdiffusion en direct et réserver des réunions en tête-à-tête sur le site de la conférence.
NanoVibronix, Inc. (Nasdaq: NAOV) wird am 1. Mai 2024 auf dem Planet MicroCap Showcase: VEGAS 2024 präsentieren. Der CEO, Brian Murphy, wird die Präsentation leiten. Investoren können den Live-Webcast verfolgen und 1x1 Meetings am Konferenzort buchen.
Positive
  • None.
Negative
  • None.

1x1 Meetings on Thursday, May 2, 2024

ELMSFORD, NY / ACCESSWIRE / April 24, 2024 / NanoVibronix, Inc. (Nasdaq:NAOV) ("NanoVibronix" or the "Company"), a medical device company that produces the UroShieldâ, PainShieldâ and WoundShieldâ Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 9:30 AM (Pacific Time). Brian Murphy, Chief Executive Officer of NanoVibronix, Inc. will be hosting the presentation and answering questions at the conclusion.

To access the live presentation, please use the following information:

Planet MicroCap Showcase: VEGAS 2024

Date: Wednesday, May 1, 2024

Time: 12:30 PM Eastern Time (9:30 AM Pacific Time)

Webcast: https://www.webcaster4.com/Webcast/Page/3026/50182

If you would like to book 1x1 investor meetings with NanoVibronix, and to attend the Planet MicroCap Showcase: VEGAS 2024, please make sure you are registered here: https://planetmicrocapshowcase.com/signup

1x1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV

The Planet MicroCap Showcase: VEGAS 2024 website is available here: https://planetmicrocapshowcase.com/

If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda": https://planetmicrocapshowcase.com/agenda

About Planet MicroCap

Planet MicroCap is a global multimedia financial news, publishing and events company focused on news dissemination, providing information, data and analytics for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space.

If you would like to attend the Planet MicroCap Showcase, please register here: https://planetmicrocapshowcase.com/signup

About NanoVibronix

NanoVibronix, Inc. (Nasdaq:NAOV) is a medical device company headquartered in Elmsford, New York, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety to medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The Company's primary products include PainShieldâ and UroShieldâ, which are portable devices suitable for administration at home without assistance of medical professionals. Additional information about NanoVibronix is available at: www.nanovibronix.com.

Forward-looking Statements

This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified; consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with: (i) market acceptance of our existing and new products or lengthy product delays in key markets; (ii) negative or unreliable clinical trial results; (iii) inability to secure regulatory approvals for the sale of our products; (iv) intense competition in the medical device industry from much larger, multinational companies; (v) product liability claims; (vi) product malfunctions; (vii) our limited manufacturing capabilities and reliance on subcontractor assistance; (viii) insufficient or inadequate reimbursements by governmental and/or other third party payers for our products; (ix) our ability to successfully obtain and maintain intellectual property protection covering our products; (x) legislative or regulatory reform impacting the healthcare system in the U.S. or in foreign jurisdictions; (xi) our reliance on single suppliers for certain product components, (xii) the need to raise additional capital to meet our future business requirements and obligations, given the fact that such capital may not be available, or may be costly, dilutive or difficult to obtain; (xiii) our conducting business in foreign jurisdictions exposing us to additional challenges, such as foreign currency exchange rate fluctuations, logistical and communications challenges, the burden and cost of compliance with foreign laws, and political and/or economic instabilities in specific jurisdictions; and (xiv) market and other conditions. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission ("SEC"), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at: http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise, except as required by law.

Investor Contacts:

Brett Maas, Managing Principal, Hayden IR, LLC
brett@haydenir.com
(646) 536-7331

SOURCE: NanoVibronix, Inc. via Planet MicroCAP LLC



View the original press release on accesswire.com

FAQ

When will NanoVibronix present at the Planet MicroCap Showcase: VEGAS 2024?

NanoVibronix will present on Wednesday, May 1, 2024, at 9:30 AM Pacific Time.

Who will be hosting the presentation at the event?

Brian Murphy, the Chief Executive Officer of NanoVibronix, will be hosting the presentation.

How can investors access the live presentation?

Investors can access the live webcast on Wednesday, May 1, 2024, at 12:30 PM Eastern Time using the following link: https://www.webcaster4.com/Webcast/Page/3026/50182.

Where will the 1x1 meetings with NanoVibronix be conducted?

The 1x1 investor meetings will be scheduled and conducted in person at the conference venue, Paris Hotel & Casino in Las Vegas, NV.

How can investors register for the Planet MicroCap Showcase: VEGAS 2024?

Investors can register for the event and book 1x1 meetings with NanoVibronix by signing up at: https://planetmicrocapshowcase.com/signup.

NanoVibronix, Inc.

NASDAQ:NAOV

NAOV Rankings

NAOV Latest News

NAOV Stock Data

2.87M
3.73M
0.69%
13.49%
4.68%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
TYLER